.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
Fuji
Healthtrust
Johnson and Johnson
Boehringer Ingelheim
QuintilesIMS
Queensland Health
Novartis
Harvard Business School

Generated: November 24, 2017

DrugPatentWatch Database Preview

CHLORAMPHENICOL Drug Profile

« Back to Dashboard

Which patents cover Chloramphenicol, and when can generic versions of Chloramphenicol launch?

Chloramphenicol is a drug marketed by Elkins Sinn, Alcon, Altana, Akorn, Fresenius Kabi Usa, and Gruppo Lepetit. and is included in six NDAs.

The generic ingredient in CHLORAMPHENICOL is chloramphenicol. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol profile page.

Medical Subject Heading (MeSH) Categories for CHLORAMPHENICOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elkins Sinn
CHLORAMPHENICOL
chloramphenicol sodium succinate
INJECTABLE;INJECTION062406-001Nov 9, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn
CHLORAMPHENICOL
chloramphenicol
SOLUTION/DROPS;OPHTHALMIC062042-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
CHLORAMPHENICOL
chloramphenicol
SOLUTION/DROPS;OPHTHALMIC062628-001Sep 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Altana
CHLORAMPHENICOL
chloramphenicol
OINTMENT;OPHTHALMIC060133-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Gruppo Lepetit
CHLORAMPHENICOL SODIUM SUCCINATE
chloramphenicol sodium succinate
INJECTABLE;INJECTION062278-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
CHLORAMPHENICOL SODIUM SUCCINATE
chloramphenicol sodium succinate
INJECTABLE;INJECTION062365-001Aug 25, 1982RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
Federal Trade Commission
Deloitte
Colorcon
QuintilesIMS
Merck
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot